Possibly more disturbing is Scott Strumello’s frustrated criticism of the ADA for their “deafening silence” on a recent call for input on guiding diabetes treatments. First off, he calls attention to a new FDA report about that agency’s …

article continues at AmyT brought to you by diabetes.medtrials.info and medtrials.info